Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Knowing when to save and when to invest is crucial for financial success. Learn how to optimize your strategy for maximum returns.
28,655 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Navitas NVTS and ON Semiconductor are capturing attention as AI data-center demand climbs. Analysts see a potential r...
A family-run frozen-food business has turned nostalgia into a nationwide snack hit, shipping 20 million soup dumpling...
A major fund is doubling down on Lionsgate Studios as shares skyrocket. Learn what know about this bet, the strategy ...
Mexico’s president confirms that the U.S. requested Iran’s World Cup training base move to Tijuana, as the 2026 tourn...
Salesforce stock has faced renewed pressure as growth slows and concerns about AI monetization persist. This pragmati...
A high-conviction AI stock has turned heads as it climbs on stronger demand for AI infrastructure and software. This ...
Microsoft rolled out a fresh coding AI family at Build, aiming to accelerate developer tooling. Investors will watch ...
An ETF that seemed to outpace the market has many investors wondering if it belongs in their portfolio. This guide ex...
Bitcoin breaches the $61,000 mark as the crypto market today, july narrative shifts toward easing inflation, ETF flow...
Abbott Laboratories and Pfizer both delivered solid Q1 2026 numbers, yet the market sentiment diverged. Abbott slumpe...
A recent CFO Form 4 shows a small share disposition at Synaptics while the company reports 10% revenue growth. This a...